Drug Type Small molecule drug |
Synonyms FQI37 |
Target |
Mechanism LSF inhibitors(transcription factor CP2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | 15 Aug 2020 | |
Hepatocellular Carcinoma | Preclinical | US | 15 Aug 2020 | |
Pancreatic Cancer | Preclinical | US | 15 Aug 2020 |